Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-09 Sale |
2024-07-11 4:51 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
30,000 | $7.2785 | $218,354 | 4,220,250 (Direct) |
View |
| 2024-07-09 Sale |
2024-07-11 4:51 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $7.315 | $83,735 | 7,167,110 (Direct) |
View |
| 2024-06-27 Sale |
2024-06-28 5:14 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $7.215 | $43,290 | 2,207,506 (Direct) |
View |
| 2024-06-25 Sale |
2024-06-27 7:13 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $9.5052 | $108,806 | 7,177,116 (Direct) |
View |
| 2024-06-13 Sale |
2024-06-17 5:46 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
30,000 | $9.296 | $278,880 | 4,329,000 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-13 5:36 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $8.4531 | $96,763 | 7,188,563 (Direct) |
View |
| 2024-06-05 Sale |
2024-06-07 4:01 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $8.71 | $871,000 | 10,249,749 (Indirect Direct) |
View |
| 2024-05-30 Sale |
2024-06-03 6:31 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
3,000 | $8.775 | $26,325 | 2,213,506 (Direct) |
View |
| 2024-05-28 Sale |
2024-05-30 6:41 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $9.1677 | $104,943 | 7,186,913 (Direct) |
View |
| 2024-05-14 Sale |
2024-05-16 4:35 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
20,054 | $10.12 | $202,934 | 7,198,360 (Direct) |
View |
| 2024-05-01 Sale |
2024-05-03 6:24 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
100,000 | $8.1 | $810,000 | 10,400,831 (Indirect Direct) |
View |
| 2024-04-30 Sale |
2024-05-02 5:41 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $7.9465 | $90,964 | 7,218,414 (Direct) |
View |
| 2024-04-25 Sale |
2024-04-29 6:41 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
3,000 | $7.6735 | $23,021 | 2,224,280 (Direct) |
View |
| 2024-04-16 Sale |
2024-04-18 5:12 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $7.6636 | $87,725 | 7,229,861 (Direct) |
View |
| 2024-04-16 Sale |
2024-04-18 5:12 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
48,124 | $7.6263 | $367,007 | 4,447,837 (Direct) |
View |
| 2024-04-03 Sale |
2024-04-05 5:44 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
130,000 | $8.93 | $1,160,900 | 4,077,835 (Indirect Direct) |
View |
| 2024-04-02 Sale |
2024-04-03 5:42 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
11,447 | $8.8182 | $100,942 | 7,241,308 (Direct) |
View |
| 2024-03-28 Sale |
2024-04-01 6:40 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
65,000 | $10.1 | $656,500 | 4,232,835 (Indirect Direct) |
View |
| 2024-03-21 Sale |
2024-03-25 6:39 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
8,000 | $10.75 | $85,980 | 2,324,031 (Direct) |
View |
| 2024-03-19 Sale |
2024-03-21 5:38 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
20,054 | $10.79 | $216,423 | 7,252,755 (Direct) |
View |
| 2024-03-12 Sale |
2024-03-14 7:28 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
50,000 | $10.74 | $537,190 | 4,570,961 (Direct) |
View |
| 2024-03-06 Sale |
2024-03-08 7:08 pm |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
61,319 | $11.73 | $719,505 | 10,784,331 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-07-09 Exercise |
2024-07-11 4:51 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
78,750 | $0 | 4,220,250 (Direct) |
View |
| 2024-07-09 Exercise |
2024-07-11 4:51 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
78,750 | $2.22 | 4,220,250 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 4:40 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,592 | $0 | 3,186,622 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 4:39 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
1,843 | $0 | 103,996 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 4:39 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
1,843 | $0 | 71,254 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-03 4:39 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
1,441 | $0 | 7,178,557 (Direct) |
View |
| 2024-06-27 Exercise |
2024-06-28 5:14 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $0 | 2,207,506 (Direct) |
View |
| 2024-06-27 Exercise |
2024-06-28 5:14 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
6,000 | $1.06 | 2,207,506 (Direct) |
View |
| 2024-06-13 Exercise |
2024-06-17 5:46 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
78,750 | $0 | 4,329,000 (Direct) |
View |
| 2024-06-13 Exercise |
2024-06-17 5:46 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
78,750 | $2.22 | 4,329,000 (Direct) |
View |
| 2024-06-05 Conversion |
2024-06-07 4:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 10,249,749 (Direct) |
View |
| 2024-06-05 Gift |
2024-06-07 4:01 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 10,249,749 (Direct) |
View |
| 2024-06-03 Option Award |
2024-06-05 6:12 pm |
N/A 2034-06-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
39,290 | $0 | 95,604 (Direct) |
View |
| 2024-06-03 Option Award |
2024-06-05 6:12 pm |
N/A 2034-06-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director |
39,290 | $0 | 77,909 (Direct) |
View |
| 2024-06-03 Option Award |
2024-06-05 6:12 pm |
N/A 2034-06-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
39,290 | $0 | 7,226,203 (Direct) |
View |
| 2024-06-03 Option Award |
2024-06-05 6:11 pm |
N/A 2034-06-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
39,290 | $0 | 128,346 (Direct) |
View |
| 2024-06-03 Option Award |
2024-06-05 6:11 pm |
N/A 2034-06-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
39,290 | $0 | 3,211,223 (Direct) |
View |
| 2024-05-30 Exercise |
2024-06-03 6:31 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
0 | $0 | 2,213,506 (Direct) |
View |
| 2024-05-30 Exercise |
2024-06-03 6:31 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
3,000 | $1.06 | 2,213,506 (Direct) |
View |
| 2024-05-15 Tax Withholding |
2024-05-17 7:12 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
9,998 | $10.01 | 2,214,282 (Direct) |
View |
| 2024-05-15 Tax Withholding |
2024-05-17 7:12 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Mauro David J Chief Medical Officer |
867 | $10.01 | 724,725 (Direct) |
View |
| 2024-05-15 Tax Withholding |
2024-05-17 7:11 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
26,082 | $10.01 | 10,374,749 (Direct) |
View |
| 2024-05-15 Tax Withholding |
2024-05-17 7:11 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
11,962 | $10.01 | 3,588,240 (Direct) |
View |
| 2024-05-02 Conversion |
2024-05-03 6:24 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
21,296 | $0 | 10,400,831 (Direct) |
View |
| 2024-05-01 Gift |
2024-05-03 6:24 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 10,400,831 (Direct) |
View |
| 2024-04-25 Exercise |
2024-04-29 6:41 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
3,000 | $0 | 2,224,280 (Direct) |
View |
| 2024-04-25 Exercise |
2024-04-29 6:41 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
3,000 | $1.06 | 2,224,280 (Direct) |
View |
| 2024-04-16 Exercise |
2024-04-18 5:12 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $0 | 4,447,837 (Direct) |
View |
| 2024-04-16 Exercise |
2024-04-18 5:12 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $2.22 | 4,447,837 (Direct) |
View |
| 2024-04-03 Conversion |
2024-04-05 5:44 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
50,000 | $0 | 4,077,835 (Indirect) |
View |
| 2024-04-03 Gift |
2024-04-05 5:44 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 4,077,835 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 5:43 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
1,267 | $0 | 3,171,933 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 5:43 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
2,001 | $0 | 60,078 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 5:43 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
1,467 | $0 | 89,056 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 5:42 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
1,467 | $0 | 56,314 (Direct) |
View |
| 2024-03-28 Conversion |
2024-04-01 6:40 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 4,232,835 (Indirect) |
View |
| 2024-03-28 Exercise |
2024-04-01 6:40 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 4,232,835 (Indirect) |
View |
| 2024-03-28 Gift |
2024-04-01 6:40 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
25,000 | $0 | 4,232,835 (Direct) |
View |
| 2024-03-21 Exercise |
2024-03-25 6:39 pm |
N/A 2028-07-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
8,000 | $0 | 2,324,031 (Direct) |
View |
| 2024-03-21 Exercise |
2024-03-25 6:39 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Marriott Tina President and COO |
8,000 | $1.06 | 2,324,031 (Direct) |
View |
| 2024-03-12 Exercise |
2024-03-14 7:28 pm |
N/A 2030-03-03 |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $0 | 4,570,961 (Direct) |
View |
| 2024-03-12 Exercise |
2024-03-14 7:28 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
75,000 | $2.22 | 4,570,961 (Direct) |
View |
| 2024-03-06 Conversion |
2024-03-08 7:08 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
35,000 | $0 | 10,784,331 (Direct) |
View |
| 2024-03-06 Exercise |
2024-03-08 7:08 pm |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
39,924 | $0 | 10,784,331 (Direct) |
View |
| 2024-03-06 Exercise |
2024-03-08 7:08 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
31,250 | $2.48 | 10,784,331 (Direct) |
View |
| 2024-03-06 Exercise |
2024-03-08 7:08 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
8,674 | $11.4 | 10,784,331 (Direct) |
View |
| 2024-03-06 Gift |
2024-03-08 7:08 pm |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer |
10,000 | $0 | 10,784,331 (Direct) |
View |